2017 - 2019年加拿大第四阶段注射吸毒者追踪调查中土著参与者的调查结果。

Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019.

作者信息

Tarasuk Jill, Sullivan Meghan, Bush Donna, Hui Christian, Morris Melissa, Starlight Tami, Cholette François, Jonah Leigh, Bryson Maggie, Paquette Dana, Masching Renée

机构信息

Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Canadian Aboriginal AIDS Network, Halifax, NS.

出版信息

Can Commun Dis Rep. 2021 Jan 29;47(1):37-46. doi: 10.14745/ccdr.v47i01a07.

DOI:10.14745/ccdr.v47i01a07

PMID:33679247

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7919774/

Abstract

BACKGROUND

The Tracks survey of people who inject drugs (PWID) collected data in 14 sentinel sites across Canada (2017-2019). These findings describe the prevalence of human immunodeficiency virus (HIV), hepatitis C and associated risk behaviours among Indigenous participants.

METHODS

Information regarding socio-demographics, social determinants of health, use of prevention services and testing, drug use, risk behaviours, and HIV and hepatitis C testing, care and treatment was collected through interviewer-administered questionnaires. Biological samples were tested for HIV, hepatitis C antibodies and hepatitis C ribonucleic acid (RNA). Descriptive statistics were calculated and reviewed by an Indigenous-led advisory group using the Two-Eyed Seeing approach.

RESULTS

Of the 2,383 participants, 997 were Indigenous (82.9% First Nations, 14.9% Métis, 2.2% Inuit). Over half (54.5%) were cisgender male and the average age was 38.9 years. A large proportion (84.0%) reported their mental health as "fair to excellent". High proportions experienced stigma and discrimination (90.2%) and physical, sexual and/or emotional abuse in childhood (87.5%) or with a sexual partner (78.6%). Use of a needle/syringe distribution program (90.5%) and testing for HIV (87.9%) and hepatitis C (87.8%) were high. Prevalence of HIV was 15.4% (78.2% were aware of infection status) and 36.4% were hepatitis C RNA-positive (49.4% were aware of infection status).

CONCLUSION

High rates of HIV and hepatitis C were identified. Challenges in access to and maintenance of HIV and hepatitis C care and treatment were noted. This information informs harm reduction strategies, including the need to scale-up awareness of prophylaxis in a culturally relevant manner.

摘要

背景

对注射毒品者（PWID）的追踪调查在加拿大14个哨点收集了数据（2017 - 2019年）。这些研究结果描述了原住民参与者中人类免疫缺陷病毒（HIV）、丙型肝炎及相关风险行为的流行情况。

方法

通过访员管理的问卷收集了有关社会人口统计学、健康的社会决定因素、预防服务的使用和检测、药物使用、风险行为以及HIV和丙型肝炎检测、护理和治疗的信息。对生物样本进行了HIV、丙型肝炎抗体和丙型肝炎核糖核酸（RNA）检测。描述性统计数据由一个由原住民领导的咨询小组采用“双眼看”方法进行计算和审查。

结果

在2383名参与者中，997名是原住民（82.9%为第一民族，14.9%为梅蒂斯人，2.2%为因纽特人）。超过一半（54.5%）为顺性别男性，平均年龄为38.9岁。很大一部分（84.0%）报告其心理健康状况为“良好至极佳”。很大比例的人经历过耻辱和歧视（90.2%）以及童年时期（87.5%）或与性伴侣相处时（78.6%）遭受身体、性和/或情感虐待。针头/注射器分发项目的使用率（90.5%）以及HIV检测率（87.9%）和丙型肝炎检测率（87.8%）都很高。HIV的流行率为15.4%（78.2%知晓感染状况），36.4%的人丙型肝炎RNA呈阳性（49.4%知晓感染状况）。